Nasal instillation of probiotic extracts inhibits experimental allergic rhinitis

Immunotherapy. 2019 Oct;11(15):1315-1323. doi: 10.2217/imt-2019-0119. Epub 2019 Sep 3.

Abstract

Aim: Allergic rhinitis (AR) is a common disease. The therapeutic efficacy of AR needs to be improved. This study aims to evaluate the effects of local administration of probiotic extracts on inhibiting experimental AR. Methods: Epithelial cells (ECs) were primed by exposing to Clostridium butyricum extracts (CBe) in the culture to upregulate the expression of IL-10. A mouse AR model was developed to assess the therapeutic potential of CBe in AR. Results: CBe markedly induced the expression of IL-10 in ECs. Co-culture of naive B cells with CBe-primed ECs significantly increased IL-10 expression in the B cells (iB10 cells). The iB10 cells showed immune suppressive function in suppressing effector CD4+ T-cell proliferation. Treatment with nasal drops containing CBe efficiently inhibited experimental AR in mice. Conclusion: Local administration of CBe can efficiently inhibit experimental AR.

Keywords: B cells; allergic rhinitis; epithelial cells; immune regulation; nasal mucosa.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intranasal
  • Animals
  • Clostridium butyricum
  • Disease Models, Animal
  • Interleukin-10 / immunology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Nasal Mucosa / immunology*
  • Probiotics*
  • Rhinitis, Allergic* / immunology

Substances

  • Interleukin-10